IVIG治疗败血症患者的有效性:系统性审查和元分析
Bo Pan1, Pan Sun1, Renjun Pei1
1Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, 610052, China.
Journal of translational medicine
|October 29, 2023
概括
静脉注射免疫球蛋白 (IVIG) 疗法有效地减少了败血症死亡率和住院时间,特别是成年人和高收入和中等收入国家的IgM丰富配方. 对低收入环境需要进一步的研究.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 败血症是一种危及生命的感染反应,具有显著的发病率和死亡率.
- 静脉注射免疫球蛋白 (IVIG) 正在作为治疗败血症的辅助疗法进行研究.
- 以往对IVIG治疗败血症的试验结果因研究变异而不一致.
研究的目的:
- 系统地评估IVIG作为败血症辅助疗法的疗效.
- 根据IVIG类型,患者年龄和经济地区分析子组影响.
主要方法:
- 一个系统的审查和31个随机对照试验 (RCTs) 的元分析,涉及6,276名参与者.
- 搜索了PubMed,Embase,Cochrane图书馆和CNKI数据库,截至2023年1月31日.
- 进行了子组分析,并评估了研究质量和偏差风险.
主要成果:
- IVIG显著降低了败血症死亡率 (RR 0.86),住院时间 (MD -4.46天) 和APACHE II分数 (MD -1.65).
- 富含IgM的IVIG显示有效性 (RR 0.55),而标准IVIG没有显著降低死亡率 (RR 0.91).
- IVIG在成年人和高收入和中等收入国家证明了益处,但在新生儿或低收入国家没有确的结果.
结论:
- 有足够的证据支持IVIG减少与败血症相关的死亡率.
- 富含IgM的IVIG对成人和新生儿败血症都有效,而标准IVIG仅对成年人有效.
- 在高收入和中等收入国家,IVIG的有效性是显而易见的,但在低收入国家,IVIG的作用需要进一步研究.
相关概念视频
01:28Pneumonia IV: Management
338
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
338
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
19
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
19